Macrophages and depression - A misalliance or well-arranged marriage?

Pharmacological Reports

Volumn 65, Issue 6, 2013, Pages 1663-1672

  Roman, Adam ^a   Kreiner, Grzegorz ^a   Nalepa, Irena ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Antidepressants; Cytokines; Depression; Electroconvulsive shock (ECS); Macrophages; Microglia

Indexed keywords

ANTIDEPRESSANT AGENT;

CELLULAR DISTRIBUTION; CHOROID PLEXUS; CLINICAL EFFECTIVENESS; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; HUMAN; IMMUNE RESPONSE; MACROPHAGE; MACROPHAGE FUNCTION; MICROGLIA; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; OUTCOME ASSESSMENT; REVIEW;

ANIMALS; ANTIDEPRESSIVE AGENTS; CENTRAL NERVOUS SYSTEM; DEPRESSION; HUMANS; INFLAMMATION; MACROPHAGES;

EID: 84894176964     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)71528-7     Document Type: Article

References (60)

1. Armulik A, Genové G, Betsholtz C: Pericytes: Developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell, 2011, 21, 193-215.
2. Banasr M, Dwyer JM, Duman RS: Cell atrophy and loss in depression: Reversal by antidepressant treatment. Curr Opin Cell Biol, 2011, 23, 730-737.
3. Belowski D, Kowalski J, Madej A, Herman ZS: Influence of antidepressant drugs on macrophage cytotoxic activity in rats. Pol J Pharmacol, 2004, 56, 837-842. (Pubitemid 40287487)
4. Beumer W, Gibney SM, Drexhage RC, Pont-Lezica L, Doorduin J, Klein HC, Steiner J et al.: The immune theory of psychiatric diseases: A key role for activated microglia and circulating monocytes. J Leukoc Biol, 2012, 92, 959-975.
5. Biswas SK, Chittezhath M, Shalova IN, Lim JY: Macrophage polarization and plasticity in health and disease. Immunol Res, 2012, 53, 11-24.
6. Dalkara T, Gursoy-Ozdemir Y, Yemisci M: Brain microvascular pericytes in health and disease. Acta Neuropathol, 2011, 122, 1-9.
7. Derecki NC, Quinnies KM, Kipnis J: Alternatively activated myeloid (M2) cells enhance cognitive function in immune compromised mice. Brain Behav Immun, 2011, 25, 379-385.
8. Dhami KS, Churchward MA, Baker GB, Todd KG: Fluoxetine and citalopram decrease microglial release of glutamate and d-serine to promote cortical neuronal viability following ischemic insult. Mol Cell Neurosci, 2013, 56, 365-374.
9. Dhir A, Kulkarni SK: Nitric oxide and major depression. Nitric Oxide, 2011, 24, 125-131.
10. Dragunow M: Meningeal and choroid plexus cells-novel drug targets for CNS disorders. Brain Res, 2013, 1501, 32-55.
11. Eyre HA, Papps E, Baune BT: Treating depression and depression-like behavior with physical activity: An immune perspective. Front Psychiatry, 2013, 4, 3. doi: 10.3389/fpsyt.2013.00003.
12. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K: Development of monocytes, macrophages, and dendritic cells. Science, 2010, 327, 656-661.
13. Ghia JE, Blennerhassett P, Deng Y, Verdu EF, Khan WI, Collins SM: Reactivation of inflammatory bowel disease in a mouse model of depression. Gastroenterology, 2009, 136, 2280-2288. e1-4.
14. Ghia JE, Park AJ, Blennerhassett P, Khan WI, Collins SM: Adoptive transfer of macrophage from mice with depression-like behavior enhances susceptibility to colitis. Inflamm Bowel Dis, 2011, 17, 1474-1489.
15. Gimeno D, Kivimäki M, Brunner EJ, Elovainio M, De Vogli R, Steptoe A, Kumari M et al.: Associations of Creactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med, 2009, 39, 413-423.
16. Haroon E, Raison CL, Miller AH: Psychoneuroimmunology meets neuropsychopharmacology: Translational implications of the impact of inflammation on behavior. Neuropsychopharmacology, 2012, 37, 137-162.
17. Hashioka S, Klegeris A, Monji A, Kato T, Sawada M, McGeer PL, Kanba S: Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide. Exp Neurol, 2007, 206, 33-42. (Pubitemid 46935120)
18. Hurley LL, Tizabi Y: Neuroinflammation, neurodegeneration, and depression. Neurotox Res, 2013, 23, 131-144.
19. Janssen DG, Caniato RN, Verster JC, Baune BT: A psychoneuroimmunological review on cytokines involved in antidepressant treatment response. Hum Psychopharmacol, 2010, 25, 201-215.
20. Jansson L, Orre K, TingströmA: Repeated electroconvulsive seizures increase the number of vessel-associatedmacrophages in rat hippocampus. J ECT, 2012, 28,174-179.
21. Jansson L, Wennström M, Johanson A, Tingström A: Glial cell activation in response to electroconvulsive seizures. Prog Neuropsychopharmacol Biol Psychiatry, 2009, 33, 1119-1128.
22. Jinno S, Kosaka T: Reduction of Iba1-expressing microglial process density in the hippocampus following electroconvulsive shock. Exp Neurol, 2008, 212, 440-447.
23. Kato TA, Kanba S: Are microglia minding us? Digging up the unconscious mind-brain relationship from a neuropsychoanalytic approach. Front Hum Neurosci, 2013, 7, 13.
24. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A: Physiology of microglia. Physiol Rev, 2011, 91, 461-553.
25. Kohman RA, Rhodes JS: Neurogenesis, inflammation and behavior. Brain Behav Immun, 2013, 27, 22-32.
26. Konsman JP, Drukarch B, Van Dam AM: (Peri)vascular production and action of pro-inflammatory cytokines in brain pathology. Clin Sci (Lond) 2007, 112, 1-25. (Pubitemid 46127195)
27. Leonard BE: The concept of depression as a dysfunction of the immune system. Curr Immunol Rev, 2010, 6, 205-212.
28. Liu RT, Alloy LB: Stress generation in depression: A systematic review of the empirical literature and recommendations for future study. Clin Psychol Rev, 2010, 30, 582-593.
29. London A, Cohen M, Schwartz M: Microglia and monocyte-derived macrophages: Functionally distinct populations that act in concert in CNS plasticity and repair. Front Cell Neurosci, 2013, 7, 34.
30. Maes M: The cytokine hypothesis of depression: Inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuro Endocrinol Lett, 2008, 29, 287-291.
31. McMenamin PG, Wealthall RJ, Deverall M, Cooper SJ, Griffin B: Macrophages and dendritic cells in the rat meninges and choroid plexus: Three-dimensional localisation by environmental scanning electron microscopy and confocal microscopy. Cell Tissue Res, 2003, 313, 259-269. (Pubitemid 37260433)
32. Medzhitov R: Origin and physiological roles of inflammation. Nature, 2008, 454, 428-435.
33. Miret M, Ayuso-Mateos JL, Sanchez-Moreno J, Vieta E: Depressive disorders and suicide: Epidemiology, risk factors, and burden. Neurosci Biobehav Rev, 2013, 37, 2372-2374.
34. Moon ML, McNeil LK, Freund GG: Macrophages make me sick: How macrophage activation states influence sickness behavior. Psychoneuroendocrinology, 2011, 36, 1431-1440.
35. Myint AM, Schwarz MJ, Müller N: The role of the kynurenine metabolism in major depression. J Neural Transm, 2012, 119, 245-251.
36. Müller N,Myint AM, SchwarzMJ: Inflammatory biomarkers and depression. Neurotox Res, 2011, 19, 308-318.
37. Obuchowicz E, Kowalski J, Labuzek K, Krysiak R, Pendzich J, Herman ZS: Amitriptyline and nortriptyline inhibit interleukin-1 release by rat mixed glial and microglial cell cultures. Int J Neuropsychopharmacol, 2006, 9, 27-35. (Pubitemid 43068332)
38. Ortega RM, Rodríguez-Rodríguez E, López-Sobaler AM: Effects of omega 3 fatty acids supplementation in behavior and non-neurodegenerative neuropsychiatric disorders. Br J Nutr, 2012, 107, Suppl 2, S261-S270.
39. Pace TW, Miller AH: Cytokines and glucocorticoid receptor signaling. Relevance to major depression. Ann NY Acad Sci, 2009, 1179, 86-105.
40. Prinz M, Priller J, Sisodia SS, Ransohoff RM: Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat Neurosci, 2011, 14, 1227-1235.
41. Ressler KJ, Nemeroff CB: Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety, 2000, 12, Suppl 1, 2-19.
42. Roman A, Kuoemierczyk J, Klimek E, Rogóz Z, Nalepa I: Effects of co-administration of fluoxetine and risperidone on properties of peritoneal and pleural macrophages in rats subjected to the forced swimming test. Pharmacol Rep, 2012, 64, 1368-1380.
43. Roman A, Nalepa I: Effect of repeated administration of paroxetine and electroconvulsive shock on the proliferative response of lymphocytes and the synthesis of nitric oxide by macrophages in rats. J ECT, 2005, 21, 111-117. (Pubitemid 40800038)
44. Roman A, Nawrat D, Nalepa I: Chronic treatment with electroconvulsive shock may modulate the immune function of macrophages. J ECT, 2008, 24, 260-267.
45. Roman A, Rogóz Z, Kubera M, Nawrat D, Nalepa I: Concomitant administration of fluoxetine and amantadine modulates the activity of peritoneal macrophages of rats subjected to a forced swimming test. Pharmacol Rep, 2009, 61, 1069-1077.
46. Ruhé HG, Mason NS, Schene AH: Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: A meta-analysis of monoamine depletion studies. Mol Psychiatry, 2007, 12, 331-359. (Pubitemid 46496835)
47. Sanacora G, Treccani G, Popoli M: Towards a glutamate hypothesis of depression: An emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology, 2012, 62, 63-77.
48. Sanchez S, Paredes SD, Sanchez CL, Barriga C, Reiter RJ, Rodriguez AB: Tryptophan administration in rats enhances phagocytic function and reduces oxidative metabolism. Neuro Endocrinol Lett, 2008, 29, 1026-1032.
49. Sherry CL, Kim SS, Dilger RN, Bauer LL, Moon ML, Tapping RI, Fahey GC Jr et al.: Sickness behavior induced by endotoxin can be mitigated by the dietary soluble fiber, pectin, through up-regulation of IL-4 and Th2 polarization. Brain Behav Immun, 2010, 24, 631-640.
50. Sica A, Mantovani A: Macrophage plasticity and polarization: In vivo veritas. J Clin Invest, 2012, 122, 787-795.
51. Smith RS: The macrophage theory of depression. Med Hypotheses, 1991, 35, 298-306.
52. Soczynska JK, Kennedy SH, Woldeyohannes HO, Liauw SS, Alsuwaidan M, Yim CY, McIntyre RS: Mood disorders and obesity: Understanding inflammation as a pathophysiological nexus. Neuromolecular Med, 2011, 13, 93-116.
53. Soczynska JK, Mansur RB, Brietzke E, Swardfager W, Kennedy SH, Woldeyohannes HO, Powell AM et al.: Novel therapeutic targets in depression: Minocycline as a candidate treatment. Behav Brain Res, 2012, 235, 302-317.
54. Sperner-Unterweger B, Kohl C, Fuchs D: Immune changes and neurotransmitters: Possible interactions in depression? Prog Neuropsychopharmacol Biol Psychiatry, 2012, pii: S0278-5846(12)00260-6. doi: 10.1016/j.pnpbp.2012.10.006.
55. Tynan RJ, Weidenhofer J, Hinwood M, Cairns MJ, Day TA, Walker FR: A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia.Brain Behav Immun, 2012, 26, 469-479.
56. Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, Lalla D et al.: Etanercept and clinical outcomes, fatigue, and depression in psoriasis: Double-blind placebo-controlled randomised phase III trial. Lancet, 2006, 367, 29-35. (Pubitemid 43038667)
57. Uzun S, Kozumplik O, Topiæ R, Jakovljeviæ M: Depressive disorders and comorbidity: Somatic illness vs. side effect. Psychiatr Danub, 2009, 21, 391-398.
58. Williams K, Alvarez X, Lackner AA: Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system. Glia, 2001, 36, 156-164. (Pubitemid 33055904)
59. Wynn TA, Chawla A, Pollard JW: Macrophage biology in development, homeostasis and disease. Nature, 2013, 496, 445-455.
60. Zunszain PA, Hepgul N, Pariante CM: Inflammation and depression. Curr Top Behav Neurosci, 2013, 14, 135-1351.